Back

Circulating metabolites in patients with chronic heart failure are related to increased lipid utilisation but not to gut microbiota alterations

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Miscellaneous clinical studies in heart failure (3) Heart Failure with Reduced Ejection Fraction (HFrEF) ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Andraz Nendl

Oslo University Hospital Ulleval, Oslo (Norway)

4 More presentations in this session

Presentation thumbnail
Is there an association of anthracyclines with HFrEF and/or HFpEF in patients treated for breast cancer or lymphoma after 30 years of follow-up? Insights from the Rochester epidemiology project
Doctor E. Tellez Garcia (Rochester, US)
Abstract Slides Video
Presentation thumbnail
A new heart transplant resource: DBD donor with out-of-hospital cardiac arrest
Doctor G. Fischetti (Bari, IT)
Abstract Slides Video
Presentation thumbnail
Ivabradine prevents doxorubicin-induced cardiotoxicity via attenuating mitochondrial dysfunction and mitochondrial dynamic imbalance in H9C2 cells and rats
Doctor A. Sripusanapan (Chiang Mai, TH)
Abstract Slides Video
Presentation thumbnail
Adipose tissue/ heart lipid transport determines cardiac diastolic function
Mr G. Trimarchi (Berlin, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Miscellaneous clinical studies in heart failure (3)

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Interaction of gut microbiota-derived metabolites with inflammatory markers and cellular rejection in advanced heart failure patients treated with heart transplantation
thumbnail
Congress Presentation
Unraveling the choline pathway in heart failure risk and outcomes: a systematic review and meta-analysis
thumbnail
Congress Presentation
The role of gut microbiota and short-chain fatty acids in patients with advanced heart failure undergoing orthotopic heart transplantation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources